Illustration of a mango revealing a glowing brain, symbolizing mangiferin's potential in glioblastoma treatment.

Can Mangiferin Make Radiation Therapy More Effective for Brain Tumors?

Rhea Morgan monogram
Rhea Morgan in Health & Wellness October 2026 • 4 min read.

"New research explores how mangiferin, a natural compound, could enhance the effects of radiation therapy in treating glioblastoma by targeting DNA repair mechanisms."


Glioblastoma multiforme (GBM) is a highly aggressive brain cancer with limited treatment options. While surgery and radiation are standard treatments, they often only provide temporary relief due to the cancer's high rate of recurrence. Researchers are constantly seeking new ways to improve the effectiveness of these treatments and extend the lives of patients.

One promising area of research focuses on DNA repair mechanisms within cancer cells. Cancer cells are more resistant to radiation therapy if they can efficiently repair the DNA damage caused by radiation. Scientists are exploring ways to inhibit these repair mechanisms, making cancer cells more vulnerable to radiation.

A recent study investigated the potential of mangiferin, a natural compound found in mangoes, to enhance the effects of radiation therapy in glioblastoma cells. Mangiferin has known anti-inflammatory and antioxidant properties. The study looked specifically at how mangiferin affects DNA repair in glioblastoma cells, with encouraging results.

AI Search Multiple angles on this topic

FAA and Security Procedures

The Federal Aviation Administration reported hiring 2,235 air traffic controller trainees in Fiscal Year 2026, described as the most in FAA history. AOPA explains that TSA security-threat determinations involve available information and an administrative review process. AOPA also reports that these regulations are found at 6 CFR Part 126 and that an unoverturned determination can end a pilot's flying career.

Translation Technology

Google Translate is described as a free service that translates words, phrases, and web pages between English and more than 100 languages. Its Chrome Web Store listing says users can highlight or right-click text and select the Translate icon. Google Translate's Google Play listing specifies text translation between 108 languages by typing.

How Mangiferin Impacts DNA Repair in Glioblastoma Cells

Illustration of a mango revealing a glowing brain, symbolizing mangiferin's potential in glioblastoma treatment.

The study's in vitro experiments showed that mangiferin decreased the proliferation of glioblastoma cells and increased DNA damage when combined with radiation. This suggests that mangiferin makes these cells more susceptible to the effects of radiation. Further investigation revealed that mangiferin specifically inhibits the non-homologous end-joining (NHEJ) pathway, a major DNA double-strand break (DSB) repair mechanism.

The NHEJ pathway is crucial for repairing DNA damage caused by radiation. By blocking this pathway, mangiferin prevents cancer cells from efficiently repairing themselves, leading to cell death. The researchers also found that mangiferin inhibits key proteins involved in the NHEJ pathway, such as serine-protein kinase ATM, TP53-binding protein 1, and γ-H2AX.

  • Mangiferin decreases glioblastoma cell proliferation.
  • Mangiferin increases DNA damage in cancer cells post-radiation.
  • Mangiferin inhibits the NHEJ DNA repair pathway.
  • Mangiferin impairs key proteins in the NHEJ pathway.
AI Search Multiple angles on this topic

Mangiferin and GBM

A PubMed search for mangiferin and glioblastoma identifies a study aiming to evaluate mangiferin's ability to inhibit glioblastoma multiforme progression. The snippet reports that screening a natural compound library identified mangiferin as a potent PFKFB3 inhibitor. The provided source material does not report clinical results or establish that mangiferin improves radiation therapy in patients.

DNA Repair Complexity

A 2018 article in Oncology Reports discusses how mangiferin inhibited double-strand-break repair and induced limited proliferation following radiation. The source states that competition and crosstalk exist between two repair pathways. Because the provided snippet does not identify the pathways by name or provide patient outcomes, it does not establish clinical effectiveness.

Importantly, mangiferin selectively inhibited DSB repair in GBM cells, without triggering similar inhibition in normal neuronal Schwann cells. In vivo experiments with tumor-bearing mice further supported these findings. Mice treated with mangiferin and radiation had smaller tumor volumes, decreased tumor weight, and prolonged lifespans. This indicates that mangiferin can increase tumor sensitivity to radiotherapy.

The Future of Mangiferin in Glioblastoma Therapy

These findings suggest that mangiferin may be a novel therapeutic drug for improving the radiation sensitivity of glioblastoma. While more research is needed to fully understand its mechanisms and potential side effects, mangiferin holds promise as an adjunctive therapy to enhance the effectiveness of radiation treatment for this challenging cancer. As research continues, mangiferin could pave the way for new treatment strategies, offering hope for improved outcomes and a better quality of life.

AI Search Multiple angles on this topic

Colorado Voting Resources

Vote.gov provides Colorado voter-registration information, including registration, status checks, and deadlines. The Colorado Secretary of State page asks whether users have a valid Social Security Number, Colorado driver's license, or Colorado identification card. The listed sources describe election and registration resources rather than mangiferin or radiation therapy.

Unrelated Online Discussions

The listed sources are Reddit pages and do not provide research on mangiferin, radiation therapy, or brain tumors. One page describes a subreddit called Legal Teens, while another concerns an unsolicited XNXX GOLD account email. The provided material therefore offers no evidence for a future outlook or next research frontier in this medical topic.

Microsoft Services

Microsoft describes its mission as helping people and businesses realize their full potential. Its website lists products and services including Microsoft 365, Copilot, Teams, Xbox, Windows, Azure, and Surface. The provided Microsoft sources do not address mangiferin, radiation therapy, brain tumors, or related systemic challenges.

Microsoft Account Access

The listed source is a Microsoft account sign-in page. It says users can sign in to manage a Microsoft account and access free online services such as Outlook, Word, Excel, and PowerPoint. It provides no information about patients, brain tumors, radiation therapy, or mangiferin.

Mangiferin's brain access and a radiosensitizer comparison

  • 1.15% of orally administered mangiferinIn a mouse study, only 1.15% of orally administered mangiferin was bioavailable; intraperitoneal administration produced markedly higher systemic levels. This describes availability in the body, not delivery to a brain tumor.[1]

What the findings mean beyond the cell experiments

The cell results point to a possible way of making irradiated glioblastoma cells less able to recover, but they do not establish that mangiferin reaches tumors in the brain after systemic administration. The mouse brain-detection findings make that delivery question important to interpreting the proposed mechanism.[1] [2] [3]

The lack of an overall-survival benefit in large randomized trials of other promising preclinical strategies is a reminder that encouraging laboratory or early-stage results do not by themselves demonstrate improved outcomes for patients.[4] [5]

How this work fits into glioblastoma research

Patients with glioblastoma have a median survival of 14 to 18 months despite multimodal treatment, providing a clinical context for efforts to improve radiotherapy response.[5]

The broader record cautions that preclinical strategies that appeared promising for glioblastoma have not yielded an overall-survival benefit in large randomized clinical trials. This places cell-based mangiferin findings well short of evidence of clinical benefit.[4]

What evidence would clarify mangiferin's prospects

  • Can a dosing approach produce measurable mangiferin in brain tissue and show that it engages its intended target there? The reported failure to detect it in brain fractions makes both delivery and target engagement unresolved.[3] [6]

Sources

  1. Mangiferin in human disease: Multifaceted mechanisms and applications (Review) (pmc.ncbi.nlm.nih.gov)
  2. Oncology ReportsMangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining (www.spandidos-publications.com)
  3. Mangiferin and its traversal into the brain. (pubmed.ncbi.nlm.nih.gov)
  4. Radioresistance in Glioblastoma and the Development of Radiosensitizers (pmc.ncbi.nlm.nih.gov)
  5. DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits (pmc.ncbi.nlm.nih.gov)
  6. The promise of DNA damage response inhibitors for the treatment of glioblastoma (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is mangiferin and why is it being researched for brain tumors?

Mangiferin is a natural compound found in mangoes being researched for its potential to enhance radiation therapy for glioblastoma. It is significant because it appears to make glioblastoma cells more vulnerable to radiation by interfering with their ability to repair DNA damage. This could improve the effectiveness of radiation treatments and potentially extend the lives of patients. Mangiferin's ability to selectively inhibit DNA repair in glioblastoma cells, without harming normal neuronal Schwann cells, is particularly promising.

2

What is Glioblastoma multiforme (GBM) and why is it so difficult to treat?

Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer. It is significant because it has limited treatment options and a high rate of recurrence, making it a particularly challenging cancer to treat. Current standard treatments like surgery and radiation often provide only temporary relief. The aggressive nature of Glioblastoma underscores the importance of research into new therapeutic strategies.

3

What is the NHEJ pathway and why is it important in cancer treatment?

The non-homologous end-joining (NHEJ) pathway is a major DNA double-strand break (DSB) repair mechanism in cells. It is crucial because it allows cells to repair DNA damage caused by radiation, making them more resistant to radiation therapy. Inhibiting the NHEJ pathway, as mangiferin appears to do, prevents cancer cells from efficiently repairing themselves, leading to cell death and increased sensitivity to radiation. Key proteins in the NHEJ pathway include serine-protein kinase ATM, TP53-binding protein 1, and γ-H2AX.

4

What did the study reveal about how mangiferin affects glioblastoma cells when combined with radiation?

The study showed that mangiferin decreased the proliferation of glioblastoma cells and increased DNA damage when combined with radiation. This is important because it indicates that mangiferin makes glioblastoma cells more susceptible to the effects of radiation. Furthermore, it was found that mangiferin specifically inhibits the NHEJ pathway, which is a major DNA double-strand break (DSB) repair mechanism. These findings suggest that mangiferin can increase tumor sensitivity to radiotherapy and improve treatment outcomes.

5

What did the in vivo experiments show about the effect of mangiferin and radiation on tumors?

In vivo experiments, conducted using tumor-bearing mice, showed that treatment with mangiferin and radiation resulted in smaller tumor volumes, decreased tumor weight, and prolonged lifespans. This is important because it provides evidence that mangiferin can enhance the effectiveness of radiation therapy in a living organism. It also suggests that mangiferin could potentially be used as an adjunctive therapy to improve outcomes for patients with glioblastoma. However, further research is needed to fully understand its mechanisms and potential side effects in humans.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.